Your browser doesn't support javascript.
loading
Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX).
Siskind, Dan; Russell, A; Gamble, C; Baker, A; Cosgrove, P; Burton, L; Kisely, S.
Afiliação
  • Siskind D; Metro South Addiction and Mental Health Service, Brisbane, Australia; University of Queensland, School of Medicine, Brisbane, Australia. Electronic address: d.siskind@uq.edu.au.
  • Russell A; University of Queensland, School of Medicine, Brisbane, Australia; Princess Alexandra Hospital, Australia.
  • Gamble C; Metro South Addiction and Mental Health Service, Brisbane, Australia; Queensland Center for Mental Health Research Brisbane, Qld, Australia.
  • Baker A; Queensland Center for Mental Health Research Brisbane, Qld, Australia.
  • Cosgrove P; Queensland Center for Mental Health Research Brisbane, Qld, Australia.
  • Burton L; Queensland Center for Mental Health Research Brisbane, Qld, Australia.
  • Kisely S; Metro South Addiction and Mental Health Service, Brisbane, Australia; University of Queensland, School of Medicine, Brisbane, Australia.
J Psychiatr Res ; 124: 9-12, 2020 05.
Article em En | MEDLINE | ID: mdl-32087425

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Clozapina / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: J Psychiatr Res Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Clozapina / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: J Psychiatr Res Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido